### **Overview** Anupam Rasayan India Ltd (ARIL) is a leading Indian custom synthesizer and manufacturer of high-value specialty chemicals, with over **41 years of operational history** dating back to its establishment in **1984**. Headquartered in Gujarat, the company has evolved into a globally competitive player, serving over **75 international and domestic clients**, including **31 multinational corporations (MNCs)**, across life sciences, agrochemicals, pharmaceuticals, polymers, and electronic chemicals segments. ARIL operates **six advanced manufacturing facilities**—four in Sachin (Surat) and two in Jhagadia (Bharuch), Gujarat—with a **combined installed capacity exceeding 30,000 metric tons (MT)** as of March 31, 2025. --- ### **Core Business Segments & Product Portfolio** ARIL’s operations are structured into two primary verticals: 1. **Life Science-Related Specialty Chemicals (87–88% of revenue)**: - **Agrochemicals**: Intermediates and active ingredients for insecticides, fungicides, and herbicides. - **Pharmaceuticals**: Key Starting Materials (KSMs) and intermediates for blockbuster drugs such as **Atorvastatin, Sitagliptin, Losartan, Vonoprazan, and Dapagliflozin**. - **Personal Care**: UV protection and antibacterial agents. 2. **Other Specialty Chemicals / Performance Materials (12–13% of revenue, growing)**: - **Polymers**: High-performance monomers, ionomers, and oligomers. - **Electronic Chemicals**: Materials for semiconductors, batteries, displays, and defense applications. - **Pigments, dyes, and specialty additives**. The company manufactures **over 80 complex specialty chemical products** using multi-step, complex chemical synthesis, with an increasing pipeline in high-margin, patented molecules. --- ### **Strategic Capabilities and Differentiators** #### **1. Backward Integration – Tanfac Acquisition** In May 2022, ARIL acquired a **~26% stake in Tanfac Industries Ltd for ₹1,530 million**, securing a **controlling interest** and becoming **one of India’s only backward-integrated fluorination players**. - **Tanfac** is a key Indian producer of **hydrofluoric acid (HF)** and **potassium fluoride (KF)**, critical raw materials for fluorination chemistry. - This integration **reduces dependency on Chinese imports** and ensures secure, cost-efficient supply of fluorinating agents. - It enables ARIL to expand into **fluorinated intermediates, battery chemicals, and niche high-value molecules**, unlocking a **$5+ billion addressable market**. #### **2. Advanced Manufacturing & R&D** - **DSIR-Accredited R&D Center**: Staffed with **over 90 scientists and researchers** focused on **fluorination, flow chemistry, and photochemistry**. - **Technologies Deployed**: - Continuous **flow chemistry** for energy-efficient, high-yield synthesis. - **Photochemistry** for sustainable, low-temperature reactions. - Over **65–90 molecules** in R&D or pilot stages, with **17+ new molecules commercialized in FY25**, including in pharma and polymers. - R&D investment of ₹32–₹273 million annually, supporting in-house process innovation and cost optimization. #### **3. Global Expansion & Business Development** - A **dedicated global business development team** supports ARIL’s presence in **Europe, Japan, the U.S., and South Korea**. - Strategic hires include **industry veterans from 3M, BASF, DuPont, and NASA**, reinforcing technical credibility in fluoropolymers, electronics, and CRAMS. - Key markets: **Japan (~33% of sales in 2–3 years), U.S. (over 10–15% by FY26), and Europe**. --- ### **Growth Drivers & Market Opportunities** #### **1. Pharmaceuticals & KSM Market** - Commercialized **over 10 pharmaceutical molecules** in the last 18 months, including **four first-to-market in India**. - Over **30 new molecules in R&D or pilot stage**, targeting the **$15 billion global KSM and intermediates market** (5% CAGR, 2023–2028). - Focus on **import substitution**, producing KSMs and intermediates for drugs currently made in **Japan and the U.S.** - Revenue from pharma segment grew from **4% (FY23) to 24% (Q1 FY26)**. #### **2. High-Performance Polymers & Electronic Chemicals** - Target **$10 billion TAM** in electronics, semiconductors, defense, aerospace, and fuel cells (4% CAGR, 2023–2028). - Launched **two high-value polymer molecules**; over **35 in development**. - Applications include **photoresists, lithography, ionomers for fuel cells, and monomers for fluoropolymers**. - **Full backward integration** on key molecules strengthens supply chain reliability. #### **3. Battery & EV Chemicals** - Entry into **lithium-ion and next-gen battery chemicals** via a **landmark LOI with Elementium Materials (U.S.)**. - **₹3,000 crore ($350–450M potential)** LOI for a **patented fluorinated component** used in EV battery electrolytes. - Commercialization expected in **FY26**, with supply to U.S. and South Korea. - Signed LOI with **E-Lyte Innovations (Europe)** to supply **Lithium Hexafluorophosphate (LiPF6)**—a key EV electrolyte—starting FY26–FY27. - Positioned as a **strategic supplier in India’s emerging battery chemical ecosystem**. --- ### **Commercial Traction & Order Book** - **Robust order book** valued at **₹14,646 crore (~$1.7 billion)** with multinational clients from **Japan, U.S., South Korea, and Europe**. - **Long-term contracts and LOIs (4–10 years)** ensure revenue visibility: - ₹1,500 crore LOI (Japan, specialty chemicals). - ₹1,100 crore LOI (U.S., life sciences). - $106 million (₹922 crore) 10-year LOI with a South Korean MNC for aviation and electronics chemicals. - **Peak revenue from LOIs expected by FY28**, with commercialization starting **FY25–FY27**. - Recent supply contracts with **U.S. and Japanese MNCs** highlight technical trust and scalability. --- ### **Capacity & Sustainability** - **Capacity Expansion**: Completed a **₹6,700 crore capex program**, increasing installed capacity to **over 29,800 MT** by FY25. - **Green Energy Commitment**: - Invested ₹593 crore in a **9.6 MW hybrid (solar + wind) power plant**, targeting **65% green energy usage**. - **Annual savings of ₹150 million** and reduced carbon footprint. - **Zero liquid discharge (ZLD)** plants and 85% solid waste recycling.